Non Small Cell Carcinoma of the Lung
2 clinical trials · Condition
◉ Watch Non Small Cell Carcinoma of the Lung
| Record | Firm | Date |
|---|---|---|
| Circulating Tumor DNA in Patients at High Risk for Lung Cancer (NCT02715102) | Pathway Genomics | 2016-06-01 |
| Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC (NCT06841874) | Nuvation Bio Inc. |
Track Non Small Cell Carcinoma of the Lung automatically
Every clearance here is in the API, with alerts when new ones post.